Ryan Shaw recently published and co-lead an article entitled "Accelerating Precision Health by Applying the Lessons Learned from Direct-to-Consumer Genomics to Digital Health Technologies" in National Academy of Medicine. Co-authors include experts from 23andMe, Color Genomics, National Academics of Sciences, Engineering and Medicine, Emory University, Indiana University, Genetic Alliance, National Institutes of Health and Duke University School of Medicine. 

Digital health technologies have emerged in recent years, providing opportunities for engaging with consumers and integrating with the health care system to realize precision medicine, defined as “an evidence-based approach to the care of people and patients that uses innovative tools and data science to customize disease prevention, detection, and treatment; improve the effectiveness and quality of care; and sustain health” [1]. These technologies—including smartphone applications (apps), wearables (e.g., Fitbit, Apple Watch), and mobile-device-based tools—can make health care and management of health and wellness more efficient for patients and clinicians and can support research. Digital health technologies offer consumers, patients, and clinicians the opportunity to interact with personal health data and the health care system in a way that has not been available previously. (Read more)